Tuberculosis and HIV-AIDS: Achievements with ARV access Dr. Humberto Costa, MD Minister of Health, Brazil.

Slides:



Advertisements
Similar presentations
Antiretroviral Therapy Standard Core Indicators. Emergency Plan for AIDS Relief 2 million people reached with ART 7 million new infects prevented 10 million.
Advertisements

The Brazilian Response to AIDS Mauro Teixeira de Figueiredo Head of the Division for Technical Cooperation International Advisory Ministry of Health Main.
Ministry of Health National STD/AIDS Programme Universal Access to Antiretroviral Therapy: The Brazilian Experience.
Strategic Information for Anti-RetroViral Treatment Programmes Workshop WHO and UNAIDS Geneva June 30- July Ties Boerma HIV Department Surveillance,
Ronald P. Hattis, MD, MPH President, Beyond AIDS December 2013 (based on a presentation at California State University, San Bernardino, 10/4/12)
1 Severe morbidity among HIV- infected patients : a comparison between a Brazilian and a French clinic based observational cohort FIOCRUZ: Prof B Grinsztejn.
TB and HIV: Tightly Linked… and Why We Should Care.
ARIAtlas.org. Global Impact TB causes nearly two million deaths a year, making it the world’s seventh most common cause of mortality. More than two billion.
MONITORING SYSTEM FOR THE ANTIRETROVIRAL THERAPY IN BRAZIL: LESSONS LEARNED AND FUTURE DIRECTIONS Marco Vitória, MD Brazilian STD/AIDS Programme - MOH.
Dr Susan Zimba –Tembo Professional Officer – WHO 1 st March 2013, Crest Golf Hotel.
Dr R.Reesaul Chest Physician Chest Clinic P. D`or Hospital
Monitoring and Evaluation Frameworks Kyiv, Ukraine May 23, 2006 MEASURE Evaluation.
Monitoring and Evaluation: A Review of Terms. Goals To provide better treatment for people with tuberculosis in Country X To achieve a treatment success.
THE RESPONSE TO HIV/AIDS AND THE WORLD OF WORK IN BRAZIL Paulo R. Teixeira, MD Brazilian STD/AIDS Program Ministry of Health.
Monitoring and Evaluation Frameworks   What is an M&E Framework?   Why do we use M&E Frameworks?   How do we develop M&E Frameworks? MEASURE Evaluation.
Status of Revised National Tuberculosis Control Program (RNTCP) in India Dr Jitendra.
Poverty and Universal Access to TB Care Services
1 Global and Regional Tuberculosis (TB) update ACSM workshop, Amman, Jordan April 13-17, 2008 Dr. Sevil Huseynova.
Challenge 4: Linking TB & HIV/AIDS Programs Kayt Erdahl, Project HOPE Rodrick Nalikungwi, Project HOPE Malawi December 18, 2008.
THE FIGHT TO STOP TB WHAT ARE WE FIGHTING? TUBERCULOSIS: THE WORLD’S NO. 1 KILLER AMONG CURABLE, INFECTIOUS DISEASES But there is hope PEOPLE WHO HAVE.
HIV Therapy for the Developing World: A Global Health Challenge Harold W. Jaffe, MD Department of Public Health University of Oxford Oxford, UK.
Combat HIV-AIDS, malaria & other diseases Goal 6..
Impact of tuberculosis screening and isoniazid preventive therapy on incidence of TB and death in the TB/HIV in Rio de Janeiro (THRio) study B. Durovni1,2,
WHY YOU NEED TO CREATE AN AWARENESS FOR AIDS Click to Continue to Next Page.
HIV and AIDS Data Hub for Asia-Pacific Review in slides Treatment Last updated: December 2014.
Sri Lankan Perspective Dr Nihal Abeysinghe M.B.,B.S., MSc, M.D. (Community Medicine) Chief Epidemiologist Ministry of Health, Nutrition & Welfare Place.
World Bank Seminar Series: Global Issues Facing Humanity Diseases without borders.
Barriers to achieving the health MDGs and how these can be overcome Action for Global Health UK Policy Conference London, 28 June 2010 Isabelle de Zoysa.
TREATMENT OF SERO-DISCORDANT COUPLES: IMPLICATIONS FOR YOUNG PEOPLE JJ KUMWENDA (FRCP-UK)
Health Organization The Challenges Facing Tuberculosis Control Blantyre Hospital, Malawi: TB Division, 3 patients per bed.
TB epidemiology in Thailand Philippe Glaziou, on behalf of the epi team Bangkok, August 2013.
Introduction to NCHHSTP National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention Office of the Director Jonathan Mermin, MD, MPH National.
HIV/AIDS Expenditures in Sub-Saharan Africa: Observations from Kenya, Rwanda and Zambia S. Muchiri, Wellington Godo, K Chebet,Ministry of Health, Nairobi,
Fabio Mesquita, MD, PhD Director of the Brazilian Ministry of Health’s HIV/AIDS and Viral Hepatitis Department July 23th, 2014 TasP – Leadership.
The National HIV Counselling and Testing Campaign and Treatment Expansion in South Africa: A return on investments in combination prevention XIX International.
Strategic Information and the Control of Tuberculosis Brian Williams and Chris Dye TB programme, Monitoring and Evaluation, WHO.
Ministry of Health Health Surveillance Secretariat NATIONAL STD/AIDS PROGRAMME.
Diagnostics - More than 100 years old Drugs – Last drug 40 years old Vaccine – Nearly 90 years old Lucica Ditiu Executive Secretary, Stop TB Partnership.
© Annual number of new reported TB cases. Data from WHO.[46][46]
MDG 6: Combat HIV/AIDS and other diseases. Where are we…  Regionally, “on track” for MDG-6 (only a few countries are progressing slowly or show no progress)
Universal Access: To what extent current mechanisms are appropriate and sustainable to maintain free of charge treatment? Compulsory Licensing in Brazil.
SPECIAL SESSION COUNTDOWN TO 2015 IN ETHIOPIA CHALLENGES AND PERSPECTIVES IN ACHIEVING MILLENNIUM DEVELOPMENT GOALS IN ETHIOPIA Sandro Accorsi Advisor,
Important diseases and their global impact Objectives To be able to describe the causes and means of transmission of malaria, AIDS/HIV and T.B To be able.
HIV/AIDS Epidemic in India Trends, Lessons, Challenges & Opportunities
Contents - HIV global slides
Addressing Viral Hepatitis
USING BUDGET FOR RESULTS IN HIV/AIDS PROGRAMS: LESSONS FROM PERU
HIV and AIDS The management of HIV and AIDS is an ongoing challenge for Anglo companies operating in countries with a high burden of HIV disease Strategy.
Overview of Global HIV Epidemic
Expanding ARV treatment in developing countries: Issues and Prospects
Progress in Implementing collaborative TB/HIV activities
TB Control in PHC network and Partners Coordination in Cambodia
Human Population China - World’s most populous country (majority male)
اپيدميولوژي و كنترل سِل
TB/HIV surveillance : Who is going to get the job done?
By: Dr Mirzaei.
WHO HIV update July 2018 Global epidemic Global progress and cascade
"3 by 5" progress December 2005.
Treatment Last updated: November 2018.
TB-HIV Last updated: November 2018.
Contents - HIV global slides
Key issues in DOTS implementation
Contents - HIV global slides
Kevin M De Cock MD CDC Kenya Nairobi, September 21, 2003
Country Presentation CAMBODIA
Improving the Use of Medications to Treat Complex Health Problems in Resource-Poor Settings: Community-Based Examples from Haiti and Peru Jennifer Furin,
THE GLOBAL EPIDEMIOLOGY OF TUBERCULOSIS WORLD HEALTH ORGANIZATION
The Global Fund to Fight AIDS, Tuberculosis and Malaria
Contents - HIV global slides
Goal 6: Combat HIV/AIDS, malaria and other diseases
Presentation transcript:

Tuberculosis and HIV-AIDS: Achievements with ARV access Dr. Humberto Costa, MD Minister of Health, Brazil

AIDS - Trends in morbidity and mortality MortalityIncidence andmortalityrates-AIDS (100,000population).Brazil, Estimatedincidence-1999–2001 Source:PN-DST-AIDS/-SVS-MOH Rate per 100,000 pop

Impact of Antiretroviral Therapy Policy ( ) Reduced Mortality  50% 90,000 deaths avoided. Reduced Morbidity  70% Reduced Hospital Admissions  80%  358,000 admissions avoided – average hospital admissions/patients per year declined from 1.65 in 1996 to 0.28 in 2001) Cost Savings  US$ 2.2 billion US$ 1.23 billion in hospitals and treatment opportunistic infections. US$ 960 million reduction in drug prices.

* Preliminary data MOH, 2003 Patient/Year - Brazil, * * Average Cost (US$) of ARV Therapy by

Nat. Incidence rate /100,000 –Highest incidence rate: Rio de Janeiro: 92/100,000 Reported cases = 92,472 –62% in 5 states; 70% in 236 cities (4%) –Detection rate – 74% –Cure rate – 72% –DOTS (%pop) – 25% Tuberculosis – Burden and inequalities

Impact of Infection Hiv - Tb Infection Tb and Hiv is one main component of the National Plan for Tuberculosis Control (2004)